Cannabidiol Market Soars to USD 36.6 Billion by 2033 || Growing Demand For Personal Care Products
December 11, 2023 02:52 ET | Market.Us
New York, Dec. 11, 2023 (GLOBE NEWSWIRE) -- According to the market.us, the global Cannabidiol Market Size was valued at USD 7.6 billion in 2023 and is anticipated to reach approximately USD 36.6...
New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder
November 24, 2023 08:55 ET | SciSparc Ltd
TEL AVIV, Israel, Nov. 24, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...
[Latest] Global Cannabidiol Market Size/Share Worth USD 19.67 Billion by 2032 at a 18% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
October 26, 2023 00:30 ET | Custom Market Insights
Austin, TX, USA, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cannabidiol Market Size, Trends and Insights By Source Type (Hemp, Marijuana),...
Global CBD Market Set to Surge to $6.17 Billion in 2023, Propelled by Growing Awareness of Medicinal Benefits and Increasing Regulatory Approvals
October 09, 2023 07:53 ET | Research and Markets
Dublin, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The "Global Cannabidiol (CBD) Market (by Product, Source, End User, Distribution Channel, & Region): Insights and Forecast with Potential Impact of...
Global Cannabidiol Market
Global Cannabidiol (CBD) Market Report 2023-2027 & 2032 Featuring Major Players - ENDOCA, Cannoid, Medical Marijuana, Inc, Folium Biosciences, & Elixinol
October 03, 2023 04:53 ET | Research and Markets
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Cannabidiol Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global cannabidiol market grew from $6.82...
Zion Market Research.jpg
CBD Gummies Market Size Will Attain USD 19.4 Billion by 2030 Registering a Promising CAGR of 29.2% - Exclusive Report by Zion Market Research | Global Cannabidiol (CBD) Gummies Market Size, Share, Trends Analysis Report
August 24, 2023 15:08 ET | Zion Market Research
SAN FRANCISCO, U.S., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “CBD Gummies Market By Concentration (Low And High), By Distribution Channel...
VPR brands logo.png
VPR Brands Announces Q2 2023 and Year to Date Financial Results 
August 16, 2023 08:22 ET | VPR Brands LP
FORT LAUDERDALE, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) -- via IBN -- VPR Brands LP (OTC: VPRB)  a licensing company owning patents and trademarks as well as a market leader for the design and sale of...
Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis
July 26, 2023 07:30 ET | Incannex Healthcare
MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique...
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
July 14, 2023 07:55 ET | SciSparc Ltd
“We hope the outcome of this trial will enable the Company to procced with commercialization process for SCI-210 in Israel" TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd....
Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis
July 13, 2023 08:00 ET | Incannex Healthcare
Highlights: Incannex has received approval from HREC for the lead site, Emeritus Research, Camberwell, VIC for the Phase 2, Blinded, Placebo Controlled Clinical Trial to Determine the Effect on Pain...